The use of dental implants in the treatment of partial or complete edentulism is on the rise as its clinical success prompts many (patients and clinicians alike) to accepting it as a standard of care. Concomitantly, on another front, there is an increasing use of bisphosphonates and other emerging antiresorptive drugs (ARDs) for the treatment of several medical conditions. These two fronts are beginning to converge, more frequently than before, as the population ages.  It is pertinent to understand how ARDs may affect dental implant treatment. The literature behind the effects of ARDs on dental implants is mixed and controversial. How do we make sense of the available evidence?

Speaker Profile:

Dr. Benjamin Ng is a specialist in Oral and Maxillofacial Surgery. He is currently an associate consultant at the National Dental Centre Singapore (NDCS). He sits on the Cranio-Maxillofacial Implant committee and the Medication Safety Committee. He completed his Bachelor of Dental Surgery at the National University of Singapore (NUS) and subsequently received his Master of Dental Surgery (MDS) in Oral and Maxillofacial Surgery by NUS. He is an accredited Oral and Maxillofacial Surgeon with the Singapore Dental Specialist Accreditation Board.

Register in advance for this meeting:

https://us02web.zoom.us/meeting/register/tZIvde6sqT4pHNE90bmEUN1qWpnbEZh3e9ZQ 

After registering, you will receive a confirmation email containing information about joining the meeting.